Nothing has changed10 Mar 2014 21:38
Somebody else wants to buy the debt. The company still wants to implement a restructuring/turnaround plan.
I still perceive the possibility of residual equity value here, but I could be wrong. I need them to return value of £12m to shareholders to make a profit
It all comes down to whether you think the company is worth more than the debt they are carrying of c. £51m. I think they are worth more than that, but then again maybe not.
H&T (which is a large component of my portfolio) currently has a market cap of £65.5m, while carrying net debt of £20.7m as of December. So enterprise value is £86.2m there (and for what it's worth, I think that will prove to be an undervaluation).
So ABM shares are worthless if Albemarle is worth less than 59% of H&T (i.e. less than £51m, or 60% of £86.2m), despite being approximately the same size and doing approximately the same thing. On the same basis, I will lose money if Albemarle is worth less than 73% of H&T (this assumes that H&T is not undervalued at current levels and in particular that the H&T valuation is not pricing in too many benefits from a potentially shrinking Albemarle).
The distress of this situation, with associated exceptional costs for restructuring, advisory fees, etc., means that Albemarle's valuation is certainly facing some serious headwinds. But let's not forget that there is still a £37 million pledge book on which an 8-9% pawn charge is being received every month. The company made an operating profit of £11.3m last year before the exceptional costs. Those who can see past the pain of short-term restructuring costs and industry consolidation could see a lot of long-term value here.
In the short-term, my research suggests that they are being more careful with the loans which they are extending now. Additionally, their gold assets should be getting a nice boost from a recovering metal price.
They are hitting against earnings-related covenants but haven't actually defaulted on any interest payments or breached the ceiling on the constrained overdraft facility.
This remains only a share for those who have the stomach to lose 100% of their investment and/or to sit through potentially painful legal procedures, given the risk of a disorderly liquidation on behalf of a creditor. It remains a distinct possibility that the shares are worthless (but as a shareholder, on the basis of the information available to us, I don't think I would vote for any procedure which gave the company an enterprise value of less than £65-70m).
Do your own research. This is just my humble opinion and is probably full of errors. I could change my mind and buy or sell at any time.